 potenti lbo strategi obviou us
messag recent media report reuter indic
discuss major privat equiti firm possibl take compani privat
believ lbo magnitud would difficult given size complex
asset continu structur pressur lack obviou exit strategi
financi sponsor make aggress set assumpt make
financi return look compel enough justifi risk pleas see lbo model
scenario analysi bodi note
bottom line lbo estim valuat roughli base
assum premium yesterday close would almost twice larg
largest lbo record note txu energi largest leverag buy-out
histori valu compani went privat txu acquir
group made kkr tpg capit goldman sach gs ultim file
bankruptci even assum ceo stefano pessina would roll
roughli ownership stake compani monet invest
still incred larg deal compar histor standard us benefit go
privat obviou compani squeez cost financi engin
growth buyback sinc walgreen boot complet merger end
simpli financi deal harvest cash flow intent exit higher multipl
road make obviou sens us situat would suggest
compani alreadi make great stride oper effici cost perspect
run lean balanc sheet take-priv strategi make sens believ
would incorpor major restructur either merg retail oper
anoth compani sell individu piec base assumpt
worth whole addit size complex remain concern
on-going structur issu rais question exit strategi
road drug retail busi face number on-going structur issu make
path forward less clear given complex involv believ likelihood
transact tradit form low share current trade
ebitda estim maintain neutral rate
make lbo compel use aggress set assumpt
order make financi return lbo sponsor compel would
appli aggress set assumpt lbo model key assumpt
includ compani taken privat rel small premium repres
ev/ebitda roughli in-lin slight premium vs suppli chain peer
yesterday close invest unconsolid subsidiari monet mainli
invest balanc sheet leverag push termin ebitda growth rate
exit multipl forward ebitda estim could debat
number assumpt would obvious impact estim financi
return howev base aggress assumpt list get return
surfac appear attract would emphas deal
magnitud come above-averag amount risk would note math
would get littl easier stefano pessina will roll full stake lbo situat
good sens intent potenti process
long-term strategi still clear oper challeng environ
structur concern includ reimburs pressur difficult fund environ
europ declin foot traffic due increas competit on-line retail
other aforement pressur may abat somewhat expect
issu continu forese futur help off-set trend embark
jv strategi help drive foot-traff altern revenu stream would
suggest strategi yield modest benefit manag benefit
strong balanc sheet healthi free cash flow given structur concern
page analyst certif import disclosur
compani yet establish path forward off-set headwind
ultim unclear longer term strategi financi sponsor would note
break busi could make sens acquir could divest wholesal
intern busi well compani stake isol
core busi make leaner easier manag new leadership team
addit note financi sponsor interest make broad-bas
structur chang compani footprint oper could easier undergo
chang magnitud privat set
expect modest pressur surpris see modest weak
buy afternoon vs flat wake
today news given ownership interest compani expect investor
concern potenti stake liquid make lbo
digest moreov last sever year wide report
discuss possibl acquir vertic integr suppli chain
reap benefit scale increas effici said taken privat
possibl deal would like decreas admittedli impact risk/
reward evalu share
potenti modest pressur lesser degre direct
impact buy sell less obviou us note
potenti larg privat competitor could drive concern around peer
oper particular risk consid could flexibl
consum price reimburs rate order better posit drive foot
traffic gain placement pharmaci network take long-term approach
expect becom meaning narr invest commun worth
note one potenti sourc concern transact realli take place
valuat risk valu ev/ebitda basi note share
current trade slight premium suppli chain peer trade
addit tweak model mainli flow refin estim regard
capit expenditur revenue/adjust ebitda estim remain
unchang respect revenue/
adjust ebitda estim vs previous
risk upsid includ acceler allevi reimburs pressur
favor gener price risk downsid includ intensifi competit
environ drive lower reimburs rate potenti on-line player take
page analyst certif import disclosur
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic walgreen boot
allianc amerisourcebergen corpor health corpor rite aid corpor next month
health corpor period preced date distribut report client guggenheim secur llc
guggenheim secur llc affili receiv compens invest bank servic health corpor past
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori walgreen boot allianc
rate price target histori amerisourcebergen corpor
creat bluematrix
page analyst certif import disclosur
creat bluematrix
rate price target histori health corpor
rate price target histori rite aid corpor
creat bluematrix
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
